Finsights Blog

Path to Pharma 2030

Founding Partner Bill Roth will present on his “Path to Pharma 2030” topic at the PCMA Annual Meeting today in Scottsdale, AZ.  This session will explore a broad view of where our industries are headed in regard to innovation, the business models we’ll need to support it, and the importance of our alignment in order to balance society’s priorities. Combining the view of the cost of health care spiraling to $4.4 trillion by the end of the decade, with continued innovation on the way in the areas of proteonomics, genomics and precision medicine, biosynthetics, AI, and more, Bill will explore likely scenarios for how they could impact our own strategies as manufacturers, payers and consumers.

Comments

*

Sign up to receive our Finsights Blog recaps by email.